Very late relapse of dapsone-induced methaemoglobinemia

Eur J Clin Pharmacol. 2010 Jun;66(6):645-6. doi: 10.1007/s00228-010-0801-x. Epub 2010 Mar 13.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / pharmacokinetics
  • Dapsone / administration & dosage
  • Dapsone / adverse effects*
  • Dapsone / pharmacokinetics*
  • Dermatitis / drug therapy
  • Dermatitis / metabolism
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / pharmacokinetics*
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / drug therapy
  • Lupus Erythematosus, Systemic / metabolism
  • Methemoglobinemia / chemically induced*
  • Methemoglobinemia / metabolism*
  • Recurrence
  • Time Factors

Substances

  • Anti-Bacterial Agents
  • Immunosuppressive Agents
  • Dapsone